Clinical activity of pembrolizumab in refractory MDM2-amplified advanced intimal sarcomas.
Saved in:
| Title: | Clinical activity of pembrolizumab in refractory MDM2-amplified advanced intimal sarcomas. |
|---|---|
| Authors: | Ribeiro MF; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada., Demicco EG; Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada., Razak ARA; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, Suit 6-445.13, 600 University Avenue, Toronto, ON M5G 1X5, Canada.; Division of Medical Oncology, Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada. |
| Source: | Therapeutic advances in medical oncology [Ther Adv Med Oncol] 2024 May 13; Vol. 16, pp. 17588359241250158. Date of Electronic Publication: 2024 May 13 (Print Publication: 2024). |
| Publication Type: | Case Reports; Journal Article |
| Journal Info: | Publisher: Sage Country of Publication: England NLM ID: 101510808 Publication Model: eCollection Cited Medium: Print ISSN: 1758-8340 (Print) Linking ISSN: 17588340 NLM ISO Abbreviation: Ther Adv Med Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
